T2 Biosystems Announces Research and Development Collaboration with Bayer to Advance Drug Monitoring and Biomarker Discovery for Blood Coagulation Disorders
July 18, 2016 08:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 18, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, has signed a multi-year...
T2 Biosystems Announces New Data at ASM Microbe 2016 Demonstrating Benefits of Adopting T2Candida® Panel for Diagnosing Sepsis in Clinical Settings
June 21, 2016 16:01 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 21, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the T2Candida®...
T2 Biosystems Announces Presentations at ASM Microbe 2016
June 08, 2016 06:30 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 08, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the T2Candida®...